Filed: 2/12/2024ACC: 0001104659-24-014002
π What this filing means
DECHENG CAPITAL LLC filed this quarterly 13FβHR report disclosing 24 equity positions with a total reported market value of $357.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$357.92M
Total AUM (reported)
39M
Total Shares
Allocation by class
COM$321.39M89.8%
CL A COM$20.12M5.6%
SHS$14.89M4.2%
COM NEW$1.24M0.3%
COM CL A$284.9K0.1%
Portfolio Concentration
Top 3$195.66M54.7%
4β10$107.24M30.0%
11β25$55.02M15.4%
Top 3 weight
54.7%
Top 10 weight
84.6%
Voting Authority Distribution
Total shares with voting rights: 39M
Sole
Full voting authority
39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings24
Rows:
Alpine Immune Sciences, Inc.
SOLEShares7.08M
TypeSH
Market value$135.01M
37.72%
Sole
7.08M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares2.10M
TypeSH
Market value$31.81M
8.89%
Sole
2.10M
Shared
0.00
None
0.00
Pacific Biosciences of California, Inc.
SOLEShares2.94M
TypeSH
Market value$28.84M
8.06%
Sole
2.94M
Shared
0.00
None
0.00
10x Genomics, Inc.
SOLEShares359.55K
TypeSH
Market value$20.12M
5.62%
Sole
359.55K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares659.93K
TypeSH
Market value$19.57M
5.47%
Sole
659.93K
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares869.79K
TypeSH
Market value$16.61M
4.64%
Sole
869.79K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares47K
TypeSH
Market value$14.88M
4.16%
Sole
47K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.28M
TypeSH
Market value$14.37M
4.02%
Sole
1.28M
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares80.86K
TypeSH
Market value$11.26M
3.15%
Sole
80.86K
Shared
0.00
None
0.00
Argenx SE
SOLEShares27.43K
TypeSH
Market value$10.43M
2.92%
Sole
27.43K
Shared
0.00
None
0.00
ACELYRIN INC(NSM)
SOLEShares1.37M
TypeSH
Market value$10.23M
2.86%
Sole
1.37M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares65.77K
TypeSH
Market value$8.16M
2.28%
Sole
65.77K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares850K
TypeSH
Market value$7.76M
2.17%
Sole
850K
Shared
0.00
None
0.00
LANTHEUS HOLDINGS INC(NMS)
SOLEShares92.20K
TypeSH
Market value$5.72M
1.60%
Sole
92.20K
Shared
0.00
None
0.00
Terns Pharmaceuticals, Inc.
SOLEShares714.28K
TypeSH
Market value$4.64M
1.30%
Sole
714.28K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$4.57M
1.28%
Sole
515.55K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.96M
TypeSH
Market value$4.45M
1.24%
Sole
4.96M
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$3.22M
0.90%
Sole
4.45M
Shared
0.00
None
0.00
AtriCure Inc.
SOLEShares46.26K
TypeSH
Market value$1.65M
0.46%
Sole
46.26K
Shared
0.00
None
0.00
Cue Health Inc.
SOLEShares8.98M
TypeSH
Market value$1.46M
0.41%
Sole
8.98M
Shared
0.00
None
0.00
Scynexis Inc.
SOLEShares555.55K
TypeSH
Market value$1.24M
0.35%
Sole
555.55K
Shared
0.00
None
0.00
Aadi Bioscience, Inc.
SOLEShares526.33K
TypeSH
Market value$1.06M
0.30%
Sole
526.33K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$588.3K
0.16%
Sole
326.81K
Shared
0.00
None
0.00
GeneDx Holdings Corp.
SOLEShares103.60K
TypeSH
Market value$284.9K
0.08%
Sole
103.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alpine Immune Sciences, Inc.SOLE | COM | 7.08M | SH | $135.01M 37.72% | 7.08M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 2.10M | SH | $31.81M 8.89% | 2.10M | 0.00 | 0.00 |
Pacific Biosciences of California, Inc.SOLE | COM | 2.94M | SH | $28.84M 8.06% | 2.94M | 0.00 | 0.00 |
10x Genomics, Inc.SOLE | CL A COM | 359.55K | SH | $20.12M 5.62% | 359.55K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 659.93K | SH | $19.57M 5.47% | 659.93K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 869.79K | SH | $16.61M 4.64% | 869.79K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 47K | SH | $14.88M 4.16% | 47K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | COM | 1.28M | SH | $14.37M 4.02% | 1.28M | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 80.86K | SH | $11.26M 3.15% | 80.86K | 0.00 | 0.00 |
Argenx SESOLE | SHS | 27.43K | SH | $10.43M 2.92% | 27.43K | 0.00 | 0.00 |
ACELYRIN INC(NSM)SOLE | COM | 1.37M | SH | $10.23M 2.86% | 1.37M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 65.77K | SH | $8.16M 2.28% | 65.77K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 850K | SH | $7.76M 2.17% | 850K | 0.00 | 0.00 |
LANTHEUS HOLDINGS INC(NMS)SOLE | COM | 92.20K | SH | $5.72M 1.60% | 92.20K | 0.00 | 0.00 |
Terns Pharmaceuticals, Inc.SOLE | COM | 714.28K | SH | $4.64M 1.30% | 714.28K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $4.57M 1.28% | 515.55K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.96M | SH | $4.45M 1.24% | 4.96M | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $3.22M 0.90% | 4.45M | 0.00 | 0.00 |
AtriCure Inc.SOLE | COM | 46.26K | SH | $1.65M 0.46% | 46.26K | 0.00 | 0.00 |
Cue Health Inc.SOLE | COM | 8.98M | SH | $1.46M 0.41% | 8.98M | 0.00 | 0.00 |
Scynexis Inc.SOLE | COM NEW | 555.55K | SH | $1.24M 0.35% | 555.55K | 0.00 | 0.00 |
Aadi Bioscience, Inc.SOLE | COM | 526.33K | SH | $1.06M 0.30% | 526.33K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $588.3K 0.16% | 326.81K | 0.00 | 0.00 |
GeneDx Holdings Corp.SOLE | COM CL A | 103.60K | SH | $284.9K 0.08% | 103.60K | 0.00 | 0.00 |